EP1546333A4 - Aspartylprotease-inhibitor als nematodenallergen - Google Patents

Aspartylprotease-inhibitor als nematodenallergen

Info

Publication number
EP1546333A4
EP1546333A4 EP03748809A EP03748809A EP1546333A4 EP 1546333 A4 EP1546333 A4 EP 1546333A4 EP 03748809 A EP03748809 A EP 03748809A EP 03748809 A EP03748809 A EP 03748809A EP 1546333 A4 EP1546333 A4 EP 1546333A4
Authority
EP
European Patent Office
Prior art keywords
allergen
nematode
protease inhibitor
aspartyl protease
aspartyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03748809A
Other languages
English (en)
French (fr)
Other versions
EP1546333A1 (de
Inventor
Margaret Mary Mcneill
Richard John Shaw
David Richard Maass
Charles Bix Shoemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ovita Ltd
Original Assignee
Ovita Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ52143402A external-priority patent/NZ521434A/en
Application filed by Ovita Ltd filed Critical Ovita Ltd
Publication of EP1546333A1 publication Critical patent/EP1546333A1/de
Publication of EP1546333A4 publication Critical patent/EP1546333A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8103—Exopeptidase (E.C. 3.4.11-19) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP03748809A 2002-09-13 2003-09-12 Aspartylprotease-inhibitor als nematodenallergen Withdrawn EP1546333A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NZ52143402A NZ521434A (en) 2002-09-13 2002-09-13 Novel allergen
NZ52143402 2002-09-13
NZ52377703 2003-01-24
NZ52377703 2003-01-24
PCT/NZ2003/000205 WO2004024922A1 (en) 2002-09-13 2003-09-12 Aspartyl protease inhibitor as a nematode allergen

Publications (2)

Publication Number Publication Date
EP1546333A1 EP1546333A1 (de) 2005-06-29
EP1546333A4 true EP1546333A4 (de) 2005-12-21

Family

ID=31996338

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03748809A Withdrawn EP1546333A4 (de) 2002-09-13 2003-09-12 Aspartylprotease-inhibitor als nematodenallergen

Country Status (5)

Country Link
EP (1) EP1546333A4 (de)
AU (1) AU2003267876A1 (de)
BR (1) BR0314273A (de)
CA (1) CA2498055A1 (de)
WO (1) WO2004024922A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102212531A (zh) * 2010-04-02 2011-10-12 复旦大学 一种重组多主枝孢霉变应原Cla h8蛋白的制备方法及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024769A2 (en) * 2002-09-13 2004-03-25 Universiteit Gent Ostertagia vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0820590A4 (de) * 1995-04-10 1999-10-20 New England Biolabs Inc Proteine von dirofilaria immitis und verfahren zur immunodiagnose des herzwurmes bei säugetieren
US6391569B1 (en) * 1996-09-18 2002-05-21 Heska Corporation Method to detect Dirofilaria immitis infection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024769A2 (en) * 2002-09-13 2004-03-25 Universiteit Gent Ostertagia vaccine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 10 February 2003 (2003-02-10), "Trichostrongylus colubriformis aspartyl protease inhibitor precursor, mRNA, complete cds.", XP002348149, retrieved from EBI accession no. EM_PRO:AY189824 Database accession no. AY189824 *
See also references of WO2004024922A1 *

Also Published As

Publication number Publication date
AU2003267876A1 (en) 2004-04-30
CA2498055A1 (en) 2004-03-25
EP1546333A1 (de) 2005-06-29
WO2004024922A1 (en) 2004-03-25
BR0314273A (pt) 2005-07-19

Similar Documents

Publication Publication Date Title
ZA200604833B (en) Heterocyclic aspartyl protease inhibitors
GB0125445D0 (en) Protease Inhibitors
NO20044258L (no) Cystein proteaseinhibitor
EP1499336A4 (de) Proteasehemmer
IL165140A0 (en) Pseudopolymorphic forms of a hiv protease inhibitor
AU2003213776A1 (en) Carbamates as hiv protease inhibitors
EP1483254A4 (de) Resistenzvermeidende inhibitoren für retrovirale proteasen
EP1704142A4 (de) Protease-inhibitoren
EP1663279A4 (de) Modifizierte proteasehemmer
AU2003247776A8 (en) Serine protease 16
AU2003269984A8 (en) Protease inhibitors
EP1546333A4 (de) Aspartylprotease-inhibitor als nematodenallergen
EP1401453A4 (de) Proteasehemmer
AU2003292406A8 (en) Serine protease
AU2003263738A8 (en) Protease inhibitors
AU2003304496A8 (en) Protease inhibitors
AU2003287325A8 (en) N-cycloalkylglycines as hiv protease inhibitors
GB0317680D0 (en) Protease assay
EP1544304A4 (de) Neue serinprotease
AU2003233642A8 (en) Protease inhibitors
AU2003252417A1 (en) Protease inhibitor
AU2003269878A8 (en) Protease inhibitors
AU2003265240A8 (en) Protease inhibitors
AU2003212249A8 (en) Engineered human kunitz-type protease inhibitor
HK1073437A (en) Protease inhibitors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050302

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20051108

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060121